Clinical manifestations related to the nervous system resulting from COVID-19: an integrative review
DOI:
https://doi.org/10.33448/rsd-v11i5.27745Keywords:
Coronavirus; Neurodegenerative diseases; Neurological manifestations.Abstract
Objetivo: analizar los principales trastornos neurológicos derivados de la infección por el virus SARS-CoV-2 (síndrome respiratorio agudo severo coronavirus 2) a través de una revisión integradora. Metodología: se trata de un estudio integrador de revisión bibliográfica. Para la selección de artículos se utilizaron dos bases de datos: PUBMED y Scielo, y se establecieron los siguientes criterios de inclusión: estudios de reporte de caso y estudios clínicos, realizados en seres humanos, disponibles en inglés, español y portugués, atribuyéndole el corte de tiempo de 1 año (2020-2021). La muestra final utilizada en esta revisión consistió en 36 artículos. Resultados y discusión: aunque el objetivo principal es el sistema respiratorio humano, el coronavirus tiene potencial neurotrópico y neuroinvasivo, teniendo la capacidad de llegar al sistema nervioso central (SNC). Así, los estudios han demostrado asociaciones entre la infección por SARS-Cov-2 y la aparición de dolor de cabeza, encefalopatía, enfermedad cerebrovascular, hemorragia cerebral, encefalomielitis, alteración de la conciencia y delirio, convulsiones tónico-clónicas, alteración del olfato y del gusto, síndrome de Guillain-Barré, rabdomiólisis, enfermedad de Parkinson, Alzheimer y esclerosis múltiple. Conclusión: de la revisión bibliográfica actual se infiere que los índices de afectación neurológica en los casos de COVID-19 son significativos y exigen el desarrollo de más estudios sobre el tema.
References
Acar, T., Acar, B. A., Aras, Y. G., Doğan, T., Boncuk, S., Eryılmaz, Halil Alper, Can, N., & Can, Y. (2020). Demographic characteristics and neurological comorbidity of patients with COVID-19. Revista Da Associação Médica Brasileira, 66, 82–85.
Acharya, A., Kevadiya, B. D., Gendelman, H. E., & Byrareddy, S. N. (2020). SARS-CoV-2 Infection Leads to Neurological Dysfunction. Journal of Neuroimmune Pharmacology: The Official Journal of the Society on NeuroImmune Pharmacology, 15(2), 167–173.
Asadi-Pooya, A. A., & Simani, L. (2020). Central nervous system manifestations of COVID-19: A systematic review. Journal of the Neurological Sciences, 413, 116832.
Banerjee, D., & Viswanath, B. (2020). Neuropsychiatric manifestations of COVID-19 and possible pathogenic mechanisms: Insights from other coronaviruses. Asian Journal of Psychiatry, 54, 102350.
Beach, S. R., Praschan, N. C., Hogan, C., Dotson, S., Merideth, F., Kontos, N., Fricchione, G. L., & Smith, F. A. (2020). Delirium in COVID-19: A case series and exploration of potential mechanisms for central nervous system involvement. General Hospital Psychiatry, 65, 47–53.
Cezar-Junior, A. B., Faquini, I. V., Silva, J. L. J., de Carvalho Junior, E. V., Lemos, L. E. A. S., Freire Filho, J. B. M., de Lira Filho, H. T., Pontes, E. C. de A., Almeida, N. S., & Azevedo-Filho, H. R. C. (2020). Subarachnoid hemorrhage and COVID-19. Medicine, 99(51), e23862.
Cheng, Q., Yang, Y., & Gao, J. (2020). Infectivity of human coronavirus in the brain. EBioMedicine, 56, 102799.
Chia, K. X., Polakhare, S., & Bruno, S. D. (2020). Possible affective cognitive cerebellar syndrome in a young patient with COVID-19 CNS vasculopathy and stroke. BMJ Case Reports, 13(10), e237926.
Chirakkal, P., Al Hail, A. N., Zada, N., & Vijayakumar, D. S. (2020). COVID-19 and Tinnitus. Ear, Nose & Throat Journal, 100(2_suppl), 160S162S.
Divani, A. A., Andalib, S., Biller, J., Di Napoli, M., Moghimi, N., Rubinos, C. A., Nobleza, C. O., Sylaja, P. N., Toledano, M., Lattanzi, S., McCullough, L. D., Cruz-Flores, S., Torbey, M., & Azarpazhooh, M. R. (2020). Central Nervous System Manifestations Associated with COVID-19. Current Neurology and Neuroscience Reports, 20(12).
Gavriatopoulou, M., Korompoki, E., Fotiou, D., Ntanasis-Stathopoulos, I., Psaltopoulou, T., Kastritis, E., … Dimopoulos, M. A. (2020). Organ-specific manifestations of COVID-19 infection. Clinical and Experimental Medicine, 20(4), 493–506.
Gklinos, P. (2020). Neurological manifestations of COVID-19: a review of what we know so far. Journal of Neurology, 267(9), 2485–2489.
Hanafi, R., Roger, P.-A. ., Perin, B., Kuchcinski, G., Deleval, N., Dallery, F., Michel, D., Hacein-Bey, L., Pruvo, J.-P. ., Outteryck, O., & Constans, J.-M. . (2020). COVID-19 Neurologic Complication with CNS Vasculitis-Like Pattern. American Journal of Neuroradiology, 41(8), 1384–1387.
Hascup, E. R., & Hascup, K. N. (2020). Does SARS-CoV-2 infection cause chronic neurological complications? GeroScience, 1–5.
Heneka, M. T., Golenbock, D., Latz, E., Morgan, D., & Brown, R. (2020). Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimer’s Research & Therapy, 12(1).
Kasal, D. A., De Lorenzo, A., & Tibiriçá, E. (2020). COVID-19 and Microvascular Disease: Pathophysiology of SARS-CoV-2 Infection With Focus on the Renin-Angiotensin System. Heart, Lung and Circulation, 29(11), 1596–1602.
Koralnik, I. J., & Tyler, K. L. (2020). COVID ‐19: A Global Threat to the Nervous System. Annals of Neurology, 88(1), 1–11.
Kordzadeh-Kermani, E., Khalili, H., & Karimzadeh, I. (2020). Pathogenesis, clinical manifestations and complications of coronavirus disease 2019 (COVID-19). Future Microbiology, 15(13), 1287–1305.
Kumar, M., & Thakur, A. K. (2020). Neurological manifestations and comorbidity associated with COVID-19: an overview. Neurological Sciences.
Leonardi, M., Padovani, A., & McArthur, J. C. (2020). Neurological manifestations associated with COVID-19: a review and a call for action. Journal of Neurology, 267(6), 1573–1576.
Lim, K.-H., Yang, S., Kim, S.-H., & Joo, J.-Y. (2020). Elevation of ACE2 as a SARS-CoV-2 entry receptor gene expression in Alzheimer’s disease. Journal of Infection, 81(3), e33–e34.
Luigetti, M., Iorio, R., Bentivoglio, A. R., Tricoli, L., Riso, V., Marotta, J., Piano, C., Primiano, G., Zileri Del Verme, L., Lo Monaco, M. R., Calabresi, P., Abbate, V., Acampora, N., Addolorato, G., Agostini, F., Ainora, M. E., Akacha, K., Amato, E., Andreani, F., & Andriollo, G. (2020). Assessment of neurological manifestations in hospitalized patients with COVID‐19. European Journal of Neurology, 27(11), 2322–2328.
MacLean, M. A., Kamintsky, L., Leck, E. D., & Friedman, A. (2020). The potential role of microvascular pathology in the neurological manifestations of coronavirus infection. Fluids and Barriers of the CNS, 17(1).
Mao, L., Jin, H., Wang, M., Hu, Y., Chen, S., He, Q., … Hu, B. (2020). Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology, 77(6), 683.
Mohammadi, S., Moosaie, F., & Aarabi, M. H. (2020). Understanding the Immunologic Characteristics of Neurologic Manifestations of SARS-CoV-2 and Potential Immunological Mechanisms. Molecular Neurobiology.
Nepal, G., Rehrig, J. H., Shrestha, G. S., Shing, Y. K., Yadav, J. K., Ojha, R., Pokhrel, G., Tu, Z. L., & Huang, D. Y. (2020). Neurological manifestations of COVID-19: a systematic review. Critical Care, 24(1).
Niazkar, H. R., Zibaee, B., Nasimi, A., & Bahri, N. (2020). The neurological manifestations of COVID-19: a review article. Neurological Sciences, 41(7), 1667–1671.
Orrù, G., Conversano, C., Malloggi, E., Francesconi, F., Ciacchini, R., & Gemignani, A. (2020). Neurological Complications of COVID-19 and Possible Neuroinvasion Pathways: A Systematic Review. International Journal of Environmental Research and Public Health, 17(18), 6688.
Payus, A. O., Liew Sat Lin, C., Mohd Noh, M., Jeffree, M. S., & Ali, R. A. (2020). SARS-CoV-2 infection of the nervous system: A review of the literature on neurological involvement in novel coronavirus disease (COVID-19). Bosnian Journal of Basic Medical Sciences.
Speth, M. M., Singer‐Cornelius, T., Oberle, M., Gengler, I., Brockmeier, S. J., & Sedaghat, A. R. (2020). Mood, Anxiety and Olfactory Dysfunction in COVID ‐19: Evidence of Central Nervous System Involvement? The Laryngoscope, 130(11), 2520–2525.
Steardo, L., Steardo, L., & Verkhratsky, A. (2020). Psychiatric face of COVID-19. Translational Psychiatry, 10(1).
Steardo, L., Steardo, L., Zorec, R., & Verkhratsky, A. (2020). Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID‐19. Acta Physiologica, 229(3).
Yavarpour-Bali, H., & Ghasemi-Kasman, M. (2020). Update on neurological manifestations of COVID-19. Life Sciences, 257, 118063.
Zhou, Z., Kang, H., Li, S., & Zhao, X. (2020). Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms. Journal of Neurology, 267(8), 2179–2184.
Zoghi, A., Ramezani, M., Roozbeh, M., Darazam, I. A., & Sahraian, M. A. (2020). A case of possible atypical demyelinating event of the central nervous system following COVID-19. Multiple Sclerosis and Related Disorders, 44, 102324.
Zubair, A. S., McAlpine, L. S., Gardin, T., Farhadian, S., Kuruvilla, D. E., & Spudich, S. (2020). Neuropathogenesis and Neurologic Manifestations of the Coronaviruses in the Age of Coronavirus Disease 2019. JAMA Neurology, 77(8), 1018.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Bianca Sampaio Lima ; Brenda Ellen Meneses Cardoso; Louise Ribeiro Teixeira; André Pessoa Silva de Bastos; Francisco Lucas Lima Paz ; José Guilherme de Oliveira Rodrigues Ferreira ; Gabriela de Souza Mendonça; Rafaela Costa Pacheco; Larruama Soares Figueiredo de Araújo ; Humberto Gabriel de Albuquerque; Charles Ponte de Sousa Filho; Ligia Viana de Araujo; Joilson Ramos de Jesus; Luan Kelves Miranda de Souza
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
